Indoco Remedies Limited (INDOCO.BO)
INR 235.05
(0.45%)
INR 235.05
(0.45%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.53 Billion INR | 8.3% |
| 2022 | 3.25 Billion INR | 4.98% |
| 2021 | 3.1 Billion INR | 30.55% |
| 2020 | 2.37 Billion INR | 14.18% |
| 2019 | 2.08 Billion INR | 13.55% |
| 2018 | 1.83 Billion INR | -5.14% |
| 2017 | 1.93 Billion INR | 3.44% |
| 2016 | 1.86 Billion INR | 12.15% |
| 2015 | 1.66 Billion INR | 10.92% |
| 2014 | 1.5 Billion INR | 36.35% |
| 2013 | 1.1 Billion INR | 18.28% |
| 2012 | 931.82 Million INR | -8.54% |
| 2011 | 1.01 Billion INR | 26.69% |
| 2010 | 804.21 Million INR | 16.35% |
| 2009 | 691.2 Million INR | 31.71% |
| 2008 | 524.8 Million INR | 0.0% |
| 2006 | 379.67 Million INR | 15.66% |
| 2005 | 328.26 Million INR | 9.02% |
| 2004 | 301.09 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.82 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 3.53 Billion INR | 8.3% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 3.55 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 3.53 Billion INR | 0.0% |
| 2022 FY | 3.25 Billion INR | 4.98% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 3.47 Billion INR | 0.0% |
| 2022 Q4 | 3.25 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 3.1 Billion INR | 30.55% |
| 2021 Q4 | 3.1 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 2.65 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 2.37 Billion INR | 0.0% |
| 2020 FY | 2.37 Billion INR | 14.18% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 2.46 Billion INR | 0.0% |
| 2019 Q2 | 1.94 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 2.08 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 2.08 Billion INR | 13.55% |
| 2018 FY | 1.83 Billion INR | -5.14% |
| 2018 Q4 | 1.83 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 1.93 Billion INR | 3.44% |
| 2016 FY | 1.86 Billion INR | 12.15% |
| 2015 FY | 1.66 Billion INR | 10.92% |
| 2014 FY | 1.5 Billion INR | 36.35% |
| 2013 FY | 1.1 Billion INR | 18.28% |
| 2012 Q4 | 931.82 Million INR | 0.0% |
| 2012 FY | 931.82 Million INR | -8.54% |
| 2011 FY | 1.01 Billion INR | 26.69% |
| 2010 FY | 804.21 Million INR | 16.35% |
| 2009 FY | 691.2 Million INR | 31.71% |
| 2008 FY | 524.8 Million INR | 0.0% |
| 2006 FY | 379.67 Million INR | 15.66% |
| 2005 FY | 328.26 Million INR | 9.02% |
| 2004 FY | 301.09 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 78.518% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 96.4% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 47.035% |
| Granules India Limited | 13 Billion INR | 72.853% |
| Achyut Healthcare Limited | 568 Thousand INR | -621484.507% |
| Ajanta Pharma Limited | 8.28 Billion INR | 57.378% |
| Alkem Laboratories Limited | 26.61 Billion INR | 86.733% |
| Alpa Laboratories Limited | 136.65 Million INR | -2483.624% |
| Brooks Laboratories Limited | 96.1 Million INR | -3573.576% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -54.931% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -145.116% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -198.073% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 94.445% |
| Eris Lifesciences Limited | 1.89 Billion INR | -86.773% |
| FDC Limited | 3.88 Billion INR | 9.213% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 85.951% |
| Gufic Biosciences Limited | 2 Billion INR | -76.105% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -3276.077% |
| Ipca Laboratories Limited | 24.71 Billion INR | 85.714% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -2254.204% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -3503.977% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1753.976% |
| Laurus Labs Limited | 18.45 Billion INR | 80.868% |
| Lupin Limited | 49.53 Billion INR | 92.873% |
| Mankind Pharma Limited | 15.53 Billion INR | 77.273% |
| Medicamen Biotech Limited | 593.75 Million INR | -494.625% |
| Medico Remedies Limited | 163.37 Million INR | -2061.08% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 49.599% |
| Piramal Pharma Limited | 21.75 Billion INR | 83.774% |
| RPG Life Sciences Limited | 1.01 Billion INR | -249.564% |
| Sigachi Industries Limited | 707.2 Million INR | -399.231% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 96.422% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -52.71% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1574.739% |
| Unichem Laboratories Limited | 7.04 Billion INR | 49.898% |
| Wanbury Limited | 360.23 Million INR | -880.091% |
| Windlas Biotech Limited | 621.89 Million INR | -467.721% |
| ZIM Laboratories Limited | 812.62 Million INR | -334.466% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 89.742% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 88.911% |
| Hester Biosciences Limited | 755.81 Million INR | -367.128% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -223.582% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -1121.462% |
| Bal Pharma Limited | 878.11 Million INR | -302.066% |
| Strides Pharma Science Limited | 11.26 Billion INR | 68.651% |
| Venus Remedies Limited | 1.21 Billion INR | -190.131% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 45.08% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 50.214% |
| Shilpa Medicare Limited | 3.44 Billion INR | -2.358% |
| Aarti Drugs Limited | 4.85 Billion INR | 27.337% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 16.896% |
| Suven Life Sciences Limited | 7.08 Million INR | -49732.04% |
| Ind-Swift Limited | 640.91 Million INR | -450.869% |
| Valiant Laboratories Limited | 100.15 Million INR | -3425.171% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 29.741% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 1.846% |
| Themis Medicare Limited | 705.74 Million INR | -400.267% |
| Hikal Limited | 3.03 Billion INR | -16.245% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 84.508% |
| Sequent Scientific Limited | 3.46 Billion INR | -1.972% |
| Novartis India Limited | 448.6 Million INR | -687.026% |
| Wockhardt Limited | 6.4 Billion INR | 44.834% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 72.623% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -13747.119% |
| Neuland Laboratories Limited | 3.5 Billion INR | -0.753% |
| Morepen Laboratories Limited | 2.48 Billion INR | -42.023% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -8753.059% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -185.555% |